Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF - Autorité des Marchés Financiers)
Press release
Avignon, April 5, 2018
31.03.2018
| Total number of outstanding shares forming the capital - 9,558,181 ordinary shares under ISIN FR0000054694 - 1,675 issued from stock-options under ISIN FR0000054694 | 9,559,856 |
| Number of shares with double voting rights | 2,921,667 |
| Total number of gross voting rights | 12,481,523 |
| Number of shares without voting rights - 4,637 bearer shares in the frame of the liquidity contract | - 4,637 |
| Total number of exercisable voting rights* | 12,476,886 |
*Real number of voting rights = total number of voting rights - number of shares without voting rights
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.fr
About Naturex
Naturex sources, manufactures and markets natural speciality ingredients for the food, health and cosmetic industries. As the Natural Maker, the company actively supports the global shift from synthetic to natural through an offer built on two main focus areas: My Natural Food and My Natural Selfcare. Naturex's portfolio includes colours, antioxidants, speciality fruits & vegetables, phytoactives, and numerous other plant-based natural ingredients, designed to create healthy, authentic and effective products.
The Group's strong commitment to quality, sustainability, continuous innovation process, and the talent of its people are at the heart of its success.
Headquartered in Avignon, France, Naturex has experienced steadily-increasing growth throughout the last 25 years. The Group employs 1,700 people worldwide and in 2017 had revenue of €405 million.
The Group is listed on Euronext Paris, Compartment B - Index: Euronext Next 150, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa - Ticker: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY
NATUREX, From Nature to You
- Investor contact
Carole Alexandre
Head of Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com